For example, FTO, as an important m6A demethylases, is related to liver lipid metabolism and has been reported increase in the patients with liver of non-alcoholic fatty liver disease (NAFLD), leading to the reduced fatty acid oxidation and elevated lipid accumulation in human hepatocytes (24, 25). This evidence concerns the gene FTO and metabolic dysfunction-associated steatotic liver disease.